Mechanism of inactivation of hepatitis B surface antigen by N(α)-cocoyl-L-arginine ethyl ester

Yoshikazu Sugimoto, S. Toyoshima

Research output: Contribution to journalArticle

2 Citations (Scopus)

Abstract

The mechanism of N(a)-cocoyl-L-arginine ethyl ester (CAE) in the inactivation of hepatitis B surface antigen (HBsAg) was investigated. The CAE increased the density of HBsAg, and particles of the antigen were destroyed in amorphous clusters, suggesting that CAE influences the lipid components of HBsAg. The lipid components such as cholesterol and phospholipid were mostly removed from the antigen by the treatment with CAE. N(α)-Lauroyl-L[U14C] arginine ethyl ester (LAE), a principal component of CAE, became tightly bound to HBsAg in place of the lipid components. The binding amounts of LAE in the HBsAg-LAE complex reached 3.04 ± 0.44 μg/mg of protein. The formation of the complex was not influenced by the presence of CAE-related compounds such as L-arginine, L-arginine ethyl ester, and N(α)-cocoyl-L-arginine. Treatment with mercaptoethanol-urea, guanidine hydrochloride, and some detergents failed to resolve appreciably the labeled LAE from the labeled complex. All attempts to reactivate the CAE-treated HBsAg and to restore it morphologically from the denatured aggregates were unsuccessful. These results indicate that CAE tightly binds to HBsAg, followed by formation of stable aggregates of the denatured HBsAg-CAE complex.

Original languageEnglish
Pages (from-to)120-127
Number of pages8
JournalAntimicrobial Agents and Chemotherapy
Volume20
Issue number1
Publication statusPublished - 1981

Fingerprint

Hepatitis B Surface Antigens
Arginine
Lipids
arginine ethyl ester
Antigens
Mercaptoethanol
Guanidine
Detergents
Urea
Phospholipids
Cholesterol

ASJC Scopus subject areas

  • Pharmacology (medical)

Cite this

Mechanism of inactivation of hepatitis B surface antigen by N(α)-cocoyl-L-arginine ethyl ester. / Sugimoto, Yoshikazu; Toyoshima, S.

In: Antimicrobial Agents and Chemotherapy, Vol. 20, No. 1, 1981, p. 120-127.

Research output: Contribution to journalArticle

@article{22cda2013c9945b8a9d36a13f45c1745,
title = "Mechanism of inactivation of hepatitis B surface antigen by N(α)-cocoyl-L-arginine ethyl ester",
abstract = "The mechanism of N(a)-cocoyl-L-arginine ethyl ester (CAE) in the inactivation of hepatitis B surface antigen (HBsAg) was investigated. The CAE increased the density of HBsAg, and particles of the antigen were destroyed in amorphous clusters, suggesting that CAE influences the lipid components of HBsAg. The lipid components such as cholesterol and phospholipid were mostly removed from the antigen by the treatment with CAE. N(α)-Lauroyl-L[U14C] arginine ethyl ester (LAE), a principal component of CAE, became tightly bound to HBsAg in place of the lipid components. The binding amounts of LAE in the HBsAg-LAE complex reached 3.04 ± 0.44 μg/mg of protein. The formation of the complex was not influenced by the presence of CAE-related compounds such as L-arginine, L-arginine ethyl ester, and N(α)-cocoyl-L-arginine. Treatment with mercaptoethanol-urea, guanidine hydrochloride, and some detergents failed to resolve appreciably the labeled LAE from the labeled complex. All attempts to reactivate the CAE-treated HBsAg and to restore it morphologically from the denatured aggregates were unsuccessful. These results indicate that CAE tightly binds to HBsAg, followed by formation of stable aggregates of the denatured HBsAg-CAE complex.",
author = "Yoshikazu Sugimoto and S. Toyoshima",
year = "1981",
language = "English",
volume = "20",
pages = "120--127",
journal = "Antimicrobial Agents and Chemotherapy",
issn = "0066-4804",
publisher = "American Society for Microbiology",
number = "1",

}

TY - JOUR

T1 - Mechanism of inactivation of hepatitis B surface antigen by N(α)-cocoyl-L-arginine ethyl ester

AU - Sugimoto, Yoshikazu

AU - Toyoshima, S.

PY - 1981

Y1 - 1981

N2 - The mechanism of N(a)-cocoyl-L-arginine ethyl ester (CAE) in the inactivation of hepatitis B surface antigen (HBsAg) was investigated. The CAE increased the density of HBsAg, and particles of the antigen were destroyed in amorphous clusters, suggesting that CAE influences the lipid components of HBsAg. The lipid components such as cholesterol and phospholipid were mostly removed from the antigen by the treatment with CAE. N(α)-Lauroyl-L[U14C] arginine ethyl ester (LAE), a principal component of CAE, became tightly bound to HBsAg in place of the lipid components. The binding amounts of LAE in the HBsAg-LAE complex reached 3.04 ± 0.44 μg/mg of protein. The formation of the complex was not influenced by the presence of CAE-related compounds such as L-arginine, L-arginine ethyl ester, and N(α)-cocoyl-L-arginine. Treatment with mercaptoethanol-urea, guanidine hydrochloride, and some detergents failed to resolve appreciably the labeled LAE from the labeled complex. All attempts to reactivate the CAE-treated HBsAg and to restore it morphologically from the denatured aggregates were unsuccessful. These results indicate that CAE tightly binds to HBsAg, followed by formation of stable aggregates of the denatured HBsAg-CAE complex.

AB - The mechanism of N(a)-cocoyl-L-arginine ethyl ester (CAE) in the inactivation of hepatitis B surface antigen (HBsAg) was investigated. The CAE increased the density of HBsAg, and particles of the antigen were destroyed in amorphous clusters, suggesting that CAE influences the lipid components of HBsAg. The lipid components such as cholesterol and phospholipid were mostly removed from the antigen by the treatment with CAE. N(α)-Lauroyl-L[U14C] arginine ethyl ester (LAE), a principal component of CAE, became tightly bound to HBsAg in place of the lipid components. The binding amounts of LAE in the HBsAg-LAE complex reached 3.04 ± 0.44 μg/mg of protein. The formation of the complex was not influenced by the presence of CAE-related compounds such as L-arginine, L-arginine ethyl ester, and N(α)-cocoyl-L-arginine. Treatment with mercaptoethanol-urea, guanidine hydrochloride, and some detergents failed to resolve appreciably the labeled LAE from the labeled complex. All attempts to reactivate the CAE-treated HBsAg and to restore it morphologically from the denatured aggregates were unsuccessful. These results indicate that CAE tightly binds to HBsAg, followed by formation of stable aggregates of the denatured HBsAg-CAE complex.

UR - http://www.scopus.com/inward/record.url?scp=0019726551&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0019726551&partnerID=8YFLogxK

M3 - Article

C2 - 7283411

AN - SCOPUS:0019726551

VL - 20

SP - 120

EP - 127

JO - Antimicrobial Agents and Chemotherapy

JF - Antimicrobial Agents and Chemotherapy

SN - 0066-4804

IS - 1

ER -